LGR5 and neoplasm: While in vivo α-LGR5scFv CAR T cells efficacy was apparent, we were unable to evaluate on-target/off-tumour toxicity in LGR5+ stem cell compartments—in vivo toxicology remains a challenge in murine models because α-LGR5 does not cross-react with the murine LGR5 protein.